Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0.
Lancet Haematol. 2022.
PMID: 36328040
Clinical Trial.
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
Wettstein L, Immenschuh P, Weil T, Conzelmann C, Almeida-Hernández Y, Hoffmann M, Kempf A, Nehlmeier I, Lotke R, Petersen M, Stenger S, Kirchhoff F, Sauter D, Pöhlmann S, Sanchez-Garcia E, Münch J.
Wettstein L, et al. Among authors: immenschuh p.
J Med Virol. 2023 Jan;95(1):e28124. doi: 10.1002/jmv.28124. Epub 2022 Sep 16.
J Med Virol. 2023.
PMID: 36056630
Free PMC article.
Item in Clipboard
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL).
Rummel MJ, et al.
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.
Lancet. 2013.
PMID: 23433739
Clinical Trial.
Item in Clipboard
Prothymosin alpha 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients.
Garbin F, Eckert K, Immenschuh P, Kreuser ED, Maurer HR.
Garbin F, et al. Among authors: immenschuh p.
Int J Immunopharmacol. 1997 Jun;19(6):323-32. doi: 10.1016/s0192-0561(97)00024-6.
Int J Immunopharmacol. 1997.
PMID: 9467751
Item in Clipboard
Prothymosin alpha1 effects on IL-2-induced expression of LFA-1 on lymphocytes and their adhesion to human umbilical vein endothelial cells.
Grünberg E, Eckert K, Maurer HR, Immenschuh P, Kreuser ED.
Grünberg E, et al. Among authors: immenschuh p.
J Interferon Cytokine Res. 1997 Mar;17(3):159-65. doi: 10.1089/jir.1997.17.159.
J Interferon Cytokine Res. 1997.
PMID: 9085941
Item in Clipboard
Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.
Eckert K, Grünberg E, Immenschuh P, Garbin F, Kreuser ED, Maurer HR.
Eckert K, et al. Among authors: immenschuh p.
J Cancer Res Clin Oncol. 1997;123(8):420-8. doi: 10.1007/BF01372545.
J Cancer Res Clin Oncol. 1997.
PMID: 9292704
Item in Clipboard
Cite
Cite